Literature DB >> 14351794

The treatment of essential hypertension with pentolinium tartrate combined with Rauwolfia alkaloids.

C W C BAIN, F ASHTON, B P JONES.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; MUSCLE RELAXANTS/therapeutic use; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh：

Substances：

Year:  1955        PMID： 14351794      PMCID： PMC2061924          DOI： 10.1136/bmj.1.4917.817

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Control of blood-pressure by combined action of reserpine and pentapyrrolidinium.

Authors:  F H SMIRK; A E DOYLE; E G McQUEEN
Journal:  Lancet       Date:  1954-07-24       Impact factor: 79.321

2.  A clinical trial of Rauwolfia serpentina in essential hypertension.

Authors:  R J VAKIL
Journal:  Br Heart J       Date:  1949-10

3.  Action of a new methonium compound in arterial hypertension; pentamethylene 1 : 5-bis-n-(n-methyl-pyrrolidinium) bitartrate (M. & B. 2050A).

Authors:  F H SMIRK
Journal:  Lancet       Date:  1953-03-07       Impact factor: 79.321
  3 in total
  4 in total

1.  Cardiac failure with reserpine.

Authors:  E MARLEY; C M PARE
Journal:  Br Med J       Date:  1956-02-04

2.  Ansolysen in the treatment of arterial hypertension.

Authors:  A DAVIGNON; G LEMIEUX; J GENEST
Journal:  Can Med Assoc J       Date:  1956-05-15       Impact factor: 8.262

3.  Ecolid: a new hypotensive agent.

Authors:  R D MAXWELL; T J G HOWIE
Journal:  Br Med J       Date:  1955-11-12

4.  Action of ecolid in man.

Authors:  F H SMIRK; M HAMILTON
Journal:  Br Med J       Date:  1956-02-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.